169 related articles for article (PubMed ID: 25572805)
1. Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway.
Yang C; He L; He P; Liu Y; Wang W; He Y; Du Y; Gao F
Med Oncol; 2015 Feb; 32(2):352. PubMed ID: 25572805
[TBL] [Abstract][Full Text] [Related]
2. Curcumin Suppresses M2 Macrophage-derived Paclitaxel Chemoresistance through Inhibition of PI3K-AKT/STAT3 Signaling.
Deswal B; Bagchi U; Kapoor S
Anticancer Agents Med Chem; 2024; 24(2):146-156. PubMed ID: 37957871
[TBL] [Abstract][Full Text] [Related]
3. IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.
Hu Z; Sui Q; Jin X; Shan G; Huang Y; Yi Y; Zeng D; Zhao M; Zhan C; Wang Q; Lin Z; Lu T; Chen Z
J Exp Clin Cancer Res; 2024 Feb; 43(1):63. PubMed ID: 38424624
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer.
Mu X; Shi W; Xu Y; Xu C; Zhao T; Geng B; Yang J; Pan J; Hu S; Zhang C; Zhang J; Wang C; Shen J; Che Y; Liu Z; Lv Y; Wen H; You Q
Cell Cycle; 2018; 17(4):428-438. PubMed ID: 29468929
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway.
Gan L; Qiu Z; Huang J; Li Y; Huang H; Xiang T; Wan J; Hui T; Lin Y; Li H; Ren G
Int J Biol Sci; 2016; 12(12):1533-1543. PubMed ID: 27994517
[TBL] [Abstract][Full Text] [Related]
6. Role of STAT3 signaling pathway in breast cancer.
Ma JH; Qin L; Li X
Cell Commun Signal; 2020 Feb; 18(1):33. PubMed ID: 32111215
[TBL] [Abstract][Full Text] [Related]
7. CD44v5 domain regulates crosstalk between TNBC cells and tumor-associated macrophages by enhancing the IL-4R/STAT3 axis.
Dai Y; Ji Z; Liang H; Jiang M; Wang L; Bao X; Liu J; Liu M; Yang C
Cancer Sci; 2024 May; ():. PubMed ID: 38700108
[TBL] [Abstract][Full Text] [Related]
8. LYVE-1
Anstee JE; Feehan KT; Opzoomer JW; Dean I; Muller HP; Bahri M; Cheung TS; Liakath-Ali K; Liu Z; Choy D; Caron J; Sosnowska D; Beatson R; Muliaditan T; An Z; Gillett CE; Lan G; Zou X; Watt FM; Ng T; Burchell JM; Kordasti S; Withers DR; Lawrence T; Arnold JN
Dev Cell; 2023 Sep; 58(17):1548-1561.e10. PubMed ID: 37442140
[TBL] [Abstract][Full Text] [Related]
9. Tumor associated macrophages deliver iron to tumor cells via Lcn2.
Duan X; He K; Li J; Cheng M; Song H; Liu J; Liu P
Int J Physiol Pathophysiol Pharmacol; 2018; 10(2):105-114. PubMed ID: 29755643
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages as an emerging target against tumors: Creating a new path from bench to bedside.
Jinushi M; Komohara Y
Biochim Biophys Acta; 2015 Apr; 1855(2):123-30. PubMed ID: 25595840
[TBL] [Abstract][Full Text] [Related]
11. Breaking the vicious cycle between breast cancer cells and tumor-associated macrophages.
Su S; Wu W; He C; Liu Q; Song E
Oncoimmunology; 2014; 3(8):e953418. PubMed ID: 25610743
[TBL] [Abstract][Full Text] [Related]
12. BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth.
Wang T; Xiao M; Ge Y; Krepler C; Belser E; Lopez-Coral A; Xu X; Zhang G; Azuma R; Liu Q; Liu R; Li L; Amaravadi RK; Xu W; Karakousis G; Gangadhar TC; Schuchter LM; Lieu M; Khare S; Halloran MB; Herlyn M; Kaufman RE
Clin Cancer Res; 2015 Apr; 21(7):1652-64. PubMed ID: 25617424
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-colony stimulating factor (CSF1) predicts breast cancer progression and mortality.
Richardsen E; Uglehus RD; Johnsen SH; Busund LT
Anticancer Res; 2015 Feb; 35(2):865-74. PubMed ID: 25667468
[TBL] [Abstract][Full Text] [Related]
14. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.
Zhou W; Ke SQ; Huang Z; Flavahan W; Fang X; Paul J; Wu L; Sloan AE; McLendon RE; Li X; Rich JN; Bao S
Nat Cell Biol; 2015 Feb; 17(2):170-82. PubMed ID: 25580734
[TBL] [Abstract][Full Text] [Related]
15. Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy.
Hughes R; Qian BZ; Rowan C; Muthana M; Keklikoglou I; Olson OC; Tazzyman S; Danson S; Addison C; Clemons M; Gonzalez-Angulo AM; Joyce JA; De Palma M; Pollard JW; Lewis CE
Cancer Res; 2015 Sep; 75(17):3479-91. PubMed ID: 26269531
[TBL] [Abstract][Full Text] [Related]
16. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide.
Genin M; Clement F; Fattaccioli A; Raes M; Michiels C
BMC Cancer; 2015 Aug; 15():577. PubMed ID: 26253167
[TBL] [Abstract][Full Text] [Related]
17. Src/STAT3-dependent heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagy.
Tan Q; Wang H; Hu Y; Hu M; Li X; Aodengqimuge ; Ma Y; Wei C; Song L
Cancer Sci; 2015 Aug; 106(8):1023-32. PubMed ID: 26041409
[TBL] [Abstract][Full Text] [Related]
18. Human breast cancer cells educate macrophages toward the M2 activation status.
Sousa S; Brion R; Lintunen M; Kronqvist P; Sandholm J; Mönkkönen J; Kellokumpu-Lehtinen PL; Lauttia S; Tynninen O; Joensuu H; Heymann D; Määttä JA
Breast Cancer Res; 2015 Aug; 17(1):101. PubMed ID: 26243145
[TBL] [Abstract][Full Text] [Related]
19. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
Li D; Ji H; Niu X; Yin L; Wang Y; Gu Y; Wang J; Zhou X; Zhang H; Zhang Q
Cancer Sci; 2020 Jan; 111(1):47-58. PubMed ID: 31710162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
